Advanced computational approaches for predicting immunotherapy response in non-small cell lung cancer based on clinical and histopathological data
Lung cancer remains one of the leading causes of cancer-related mortality worldwide, with most patients diagnosed at advanced stages where curative treatment is rarely possible. In advanced non-small cell lung cancer (NSCLC), immune checkpoint inhibitors (ICIs) have significantly improved patient outcomes by enhancing...